Bluefin Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-38,645
Closed -$6.84M 535
2020
Q1
$6.84M Buy
+38,645
New +$7.28M 0.88% 26
2019
Q4
Sell
-1,600
Closed -$289K 782
2019
Q3
$269K Sell
1,600
-27,148
-94% -$4.42M 0.04% 244
2019
Q2
$4.81M Buy
+28,748
New +$3.98M 0.68% 20
2018
Q1
Sell
-47,552
Closed -$7.78M 633
2017
Q4
$7.78M Sell
47,552
-72,205
-60% -$13M 0.47% 31
2017
Q3
$24.5M Buy
119,757
+88,511
+283% +$20.6M 2.89% 8
2017
Q2
$7.6M Sell
31,246
-37,479
-55% -$8.81M 0.82% 20
2017
Q1
$16.4M Buy
68,725
+65,748
+2,209% +$15.3M 2.14% 7
2016
Q4
$625K Sell
2,977
-407,752
-99% -$84.5M 0.04% 198
2016
Q3
$94.6M Sell
410,729
-33,265
-7% -$8.13M 3.47% 4
2016
Q2
$103M Buy
+443,994
New +$102M 10.19% 1
2014
Q1
Sell
-14,369
Closed -$2.41M 563
2013
Q4
$2.41M Buy
+14,369
New +$2.25M 0.19% 113

Other funds holding AGN

Bluefin Capital Management's AGN Position: Q2 2020 in Review

Bluefin Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 38,645 shares — an estimated $6.84M sold.

Bluefin Capital Management first reported a position in AGN in Q4 2013 and held it in 11 quarters. The position peaked at $103M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bluefin Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 38,645 Allergan plc shares in Q2 2020, an estimated $6.84M.
  • Bluefin Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 11 quarters.
  • Bluefin Capital Management's Allergan plc position peaked at $103M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bluefin Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.